GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 207 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q1 2019. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $5,514,000 | -90.5% | 100,000 | -86.3% | 0.14% | -95.1% |
| Q4 2019 | $58,028,000 | -39.1% | 730,000 | -59.4% | 2.95% | -37.8% |
| Q1 2019 | $95,274,000 | +3.2% | 1,800,000 | -20.0% | 4.75% | +8.3% |
| Q4 2018 | $92,363,000 | +17.1% | 2,250,000 | +8.4% | 4.38% | +29.9% |
| Q3 2018 | $78,850,000 | -20.7% | 2,075,000 | -5.7% | 3.37% | -11.8% |
| Q2 2018 | $99,440,000 | +71.6% | 2,200,000 | +83.3% | 3.83% | +34.4% |
| Q1 2018 | $57,960,000 | +84.1% | 1,200,000 | +50.0% | 2.85% | +84.7% |
| Q4 2017 | $31,480,000 | – | 800,000 | – | 1.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fernwood Investment Management, LLC | 327,905 | $17,248,000 | 9.44% |
| Asymmetry Capital Management, L.P. | 314,217 | $16,528,000 | 8.95% |
| Perceptive Advisors | 5,775,726 | $303,803,000 | 6.97% |
| NEXTHERA CAPITAL LP | 142,305 | $7,485,000 | 6.23% |
| Grace Capital | 244,914 | $12,882,000 | 6.14% |
| Broadfin Capital, LLC | 316,619 | $16,654,000 | 3.62% |
| Ghost Tree Capital, LLC | 300,000 | $15,780,000 | 3.27% |
| ArchPoint Investors | 156,635 | $8,239,000 | 2.61% |
| STANSBERRY ASSET MANAGEMENT, LLC | 114,562 | $6,026,000 | 2.37% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 13,928 | $733,000 | 2.07% |